Psilocybin could be an unexpected avenue for treating an injury that currently has few options beyond rest and symptom management.
Articles on Psychedelics
Displaying 1 - 20 of 72 articles
Huachuma, the Andean cactus better known as San Pedro, contains mescaline, a psychoactive compound that alters perception and mood.
Brains scans show a signature linked to a dissolved separation between the self and the world.
The psychiatrist used to have to stay with the patient during their entire session. Now they’ll be able to leave the room after administering the drug.
Doctors working in palliative care see promise in emerging therapies involving psychedelic drugs, but say many questions still need to be addressed.
What five decades of research has taught us about surviving death.
Our trial found psilocybin worked fast and lasted months, but unpicking the drug’s true effect from patients’ expectations remains a challenge.
Psilocybin falls into a regulatory gray zone, with strict limitations around how it can be studied. As a result, very little is known about its health risks, despite its surging popularity.
How psychedelics induce intense visuals.
Psychedelic medicine is surging back into favour in 2025, but the very features that make these drugs promising may be the hardest to commercialise.
Psychedelic plants and fungi grow all over the planet.
Magic mushrooms and LSD may do more than bend minds: they could fight inflammation linked to depression, arthritis and heart disease.
The discovery could also make the production of psilocybin in the lab more sustainable.
Participants report life-changing effects years after psilocybin treatment.
The magic mushroom longevity study that’s too good to be true.
Several religious groups have historically used psychedelics for healing. Now, a growing number are pushing for their use as a way to mystical experiences.
Psychedelic-assisted therapy offers promise. But new research highlights concerns about safety and accessibility.
What the psychedelic DMT can tell us about near death experiences.
Psychedelics are marketed as a way for the general population to extract more work out of their already overworked lives, and to be happy about it in the process.
Researchers in American scanned the ‘hell out of’ participants brains while they tripped on mushrooms.
Top contributors
-
Senior Lecturer of Addiction, Edith Cowan University
-
PhD Candidate, Congnitive Neuroscience, University of Toronto
-
PhD student in Clinical Psychology, York University, Canada
-
Associate Professor, Cognitive Psychology, Leiden University
-
Director, Executive Leadership Academy, University of California, Berkeley
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Distinguished Professor of Neurology and Psychiatry, Director of Psychedelics Division at Neuroscape, University of California, San Francisco
-
Research fellow, Swinburne University of Technology
-
Research Assistant in Psychiatry, University of Cambridge
-
Senior Clinical Lecturer & Consultant Psychiatrist, King's College London
-
Professor, Brain Institute, Universidade Federal do Rio Grande do Norte (UFRN)
-
Universidade Federal do Rio Grande do Norte (UFRN)
-
Assistant Professor, Department of Chemistry; Department of Biochemistry & Molecular Medicine; Center for Neuroscience, University of California, Davis
-
Professor of Neuropsychopharmacology, Imperial College London
-
Associate Professor, Behavioural Pharmacology Research Unit, Johns Hopkins University